Pune, India -- (SBWIRE) -- 09/11/2018 -- Growing pharmaceuticals industries to promote the growth of life science instrumentation market

The pharmaceuticals companies are the largest consumers of life science instrumentation. The global pharmaceuticals industries are growing at a faster rate owing to incremental research and development activities, introduction of new technologies. The market growth of Life Science Instrumentation is driven by the factors such as rapidly growing demand of analytical instruments and rapidly growing pharmaceutical industry. In addition, Growing healthcare industries and government support for life science sector are escalating the growth of life science instrumentation market worldwide.

Download FREE Sample Copy Of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1380

Bruker Announced the Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH

Bruker Corporation (NASDAQ: BRKR ) announced that is has signed a definitive agreement to acquire a majority interest in Hain Lifescience GmbH, which is headquartered in Nehren, Germany. Hain is an infectious disease molecular diagnostics (MDx) specialist with a broad range of MDx solutions for the detection of microbial and viral pathogens, for antibiotic resistance testing, as well as for human genetic diseases.  Hain is already a profitable company, and in 2018 Hain expects to generate revenues of about $38 million.  Bruker expects to acquire an 80% majority interest in Hain, with options for the remaining 20% that can be exercised after 2021.  The majority acquisition is expected to close during the fourth quarter of 2018, subject to customary closing conditions and required regulatory approvals.  Financial details were not disclosed.

Get Best Discount On This Report: https://www.infiniumglobalresearch.com/reports/request-discount/1380

Hain Lifescience's offerings include consumables and instruments for DNA sample preparation, the GenoType™ assay portfolio for tuberculosis detection, for sexually transmitted disease (STD) testing, and for HIV viral load testing, as well as for other infectious disease and human genetic disease MDx tests.  Hain is particularly well-known in the field of MDx testing of tuberculosis and other mycobacterial infections.  The availability of Hain kits is subject to country-specific diagnostics regulations, and most Hain MDx assays are CE-IVD marked.  The planned acquisition of Hain will broaden Bruker's presence in the infectious disease and molecular diagnostics markets, in line with the microbiology and diagnostics initiative within Bruker's Project Accelerate portfolio transformation.

North America dominates the market of life science instruments

North America is the leading geographical segment in the life science instrumentation market due to favorable government policies, developed healthcare infrastructure and presence of leading players. Europe is the second largest region owing to the growing adoption life science instrumentation in the healthcare sector.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global life science instrumentation market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of life science instrumentation market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the life science instrumentation market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the life science instrumentation market to understand the present and future trends in this market and formulate their strategies accordingly.

About Infinium Global Research
Infinium Global Research and Consulting Solutions is started with a single motto of being business partner of first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that 'if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.